Allogene Therapeutics ALLO
NASDAQ ALLO
$0.90 -0.03 (-3.41%)
At close: Nov 11, 2026 · 4:00 PM EST

Allogene Therapeutics (ALLO) Return on Assets [ROA] (2018 - 2026)

Updated

Allogene Therapeutics' Return on Assets [ROA] was -35.05% in Q2 2026, up 12.66 percentage points from -47.71% a year earlier and up 7.83 percentage points from the prior quarter.

Analysis

Allogene Therapeutics (ALLO) Return on Assets [ROA] (2018 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Allogene Therapeutics came in at -39.58%, up 3.66 percentage points from FY2024.

  • Return on Assets [ROA] shows a five-year change of -13.86 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -43.24% in FY2024 (+1.46 pp), -44.70% in FY2023 (-9.34 pp), -35.35% in FY2022 (-12.79 pp) and -22.56% in FY2021 (+3.16 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] since Q3 2022.
  • Compared with a year earlier, Return on Assets [ROA] was higher in three of the last eight quarters, with an average year-over-year change of +1.09 percentage points.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2026 (a gain of 12.66 percentage points); the worst was Q1 2023 (a drop of 22.13 percentage points).
  • Per Business Quant data, ALLO's Return on Assets [ROA] in the three quarters before Q2 2026 was -42.89% (Q1 2026), -44.67% (Q4 2025) and -46.04% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Allogene Therapeutics 322.04 Mn -820.62 Mn - -32.93%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -32.93%
Jun 30, 2026 -35.05%
Mar 31, 2026 -42.89%
Dec 31, 2025 -44.67%
Sep 30, 2025 -47.72%
Jun 30, 2025 -49.53%
Mar 31, 2025 -48.36%
Sep 30, 2024 -44.42%
Jun 30, 2024 -43.16%
Mar 31, 2024 -44.98%
Dec 31, 2023 -45.63%
Sep 30, 2023 -43.62%
Jun 30, 2023 -45.82%
Mar 31, 2023 -44.34%
Dec 31, 2022 -38.57%
Sep 30, 2022 -25.45%
Jun 30, 2022 -23.91%
Mar 31, 2022 -22.21%
Dec 31, 2021 -16.76%
Sep 30, 2021 -22.57%
API Access

Allogene Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ALLO&period=max&api_key=YOUR_API_KEY